1 rich Libsyn https://www.libsyn.com 300 600 🧬 Can a thymus-derived peptide help overcome age-related resistance to cancer immunotherapy? A fascinating new study identifies thymulin as a key regulator of age-associated inflammation. In preclinical models, thymulin reduced pro-inflammatory myeloid activity, inhibited NF-κB signaling, enhanced T-cell immunity, and restored responsiveness to anti-PD-L1 therapy in aged hosts. While clinical translation remains to be established, the work highlights the intriguing thymus–myeloid axis as a potential therapeutic target in older adults with cancer. 🎙️ More insights on Dr RR Baliga’s Podkast for the Kurious Doc—Where Curiosity Meets Clarity! Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity! http://www.MasterMedFacts.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/42187035/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/204384995